Stock Floundering in Session: Sage Therapeutics, Inc. (NASDAQ:SAGE)

Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) have been moving lower in early trading. At the time of writing, the stock had slid down -8.72% since the open. This downward move has put the stock in the top loser category moving into the second half of the trading period.Sage Therapeutics, Inc. (NASDAQ:SAGE) is seeing declines so far in today’s trading session.  Shares are moving -8.72% lower on solid volume. The stock has landed on the top loser list for the day according to Finviz data.  

Sage Therapeutics, Inc.(NASDAQ:SAGE)‘s stock has performed at 85.37% year to date.  Breaking that down further, it has performed 44.53% for the week, 54.28% for the month, 11.63% over the last quarter, 34.83% for the past half-year and 83.43% for this last year. 

Sage Therapeutics, Inc.’s stock is   26.91% away from its 20-Day Simple Moving Average.  Extending back, their stock is trading 27.27% from the 50-Day Simple Moving Average, looking even further back, they are trading 21.66% off of the 200-Day Simple Moving Average.  In comparing the current level to recent highs and lows, the stock is -13.43% from the 50-Day High and 45.03% off the 50-day low.

 We should also note their 52-Week High and Low:  the shares currently trade -13.43% away from their high and 93.93% from the low.

RECOMMENDATIONS

Considering the above information, analysts have given a consensus recommendation of 1.70.  This is according to the brokerage firms polled by Thomson Reuters.  

Leave a Comment